# Closed-Loop Diabetes Management System
## Comprehensive Planning Documentation

**Project:** DiabetesCare Loop (Working Title)
**Version:** 1.0
**Date:** 2025-11-23
**Status:** Planning Phase

---

## Executive Summary

This repository contains comprehensive planning documentation for a closed-loop diabetes management system designed for Type 1 Diabetes patients. The system integrates continuous glucose monitoring (CGM), insulin pump control, and machine learning algorithms to automate insulin delivery with minimal user intervention.

**Key Objectives:**
- Automate insulin delivery to achieve >70% Time in Range (70-180 mg/dL)
- Reduce user burden to <5 interactions per day
- Prevent hypoglycemic events through predictive algorithms
- Obtain FDA Class III medical device approval

**Timeline to Launch:** 48-52 months (4+ years)

**Estimated Budget:** $30-50 million

---

## Document Index

### Core Planning Documents

#### 01. [Product Requirements Document (PRD)](./01_PRODUCT_REQUIREMENTS.md)
**Purpose:** Defines what we're building and why

**Key Contents:**
- Product vision and goals
- Target users and use cases
- Feature requirements (must-have, should-have, nice-to-have)
- Success metrics (TIR, HbA1c, user satisfaction)
- Regulatory requirements overview
- Out of scope items

**Read this if:** You want to understand the product vision, features, and requirements

---

#### 02. [System Architecture Document](./02_SYSTEM_ARCHITECTURE.md)
**Purpose:** High-level technical architecture

**Key Contents:**
- System components and interactions
- Technology stack (Python 3.12+, FastAPI, iOS/Android)
- Data flow diagrams
- Infrastructure design (AWS, Kubernetes)
- Integration architecture (Dexcom, Omnipod)
- Security architecture
- Scalability strategy

**Read this if:** You want to understand how the system is structured technically

---

#### 03. [Technical Design Specification](./03_TECHNICAL_DESIGN.md)
**Purpose:** Detailed implementation design

**Key Contents:**
- Backend service design (Python/FastAPI)
- Mobile app design (Swift/Kotlin)
- Database schema (PostgreSQL, TimescaleDB)
- API design (RESTful + WebSocket)
- Device communication protocols
- Algorithm implementation details

**Read this if:** You're implementing the system and need detailed technical specs

---

#### 04. [ML/AI Strategy Document](./04_ML_AI_STRATEGY.md)
**Purpose:** Machine learning and algorithm strategy

**Key Contents:**
- Glucose prediction models (LSTM, Transformer, XGBoost ensemble)
- Insulin dosing algorithms (MPC + Reinforcement Learning)
- Meal and exercise impact models
- Personalization strategy
- Model training and validation
- Production ML infrastructure
- Safety validation for ML

**Read this if:** You're working on the ML/AI components or want to understand the algorithms

---

#### 05. [Regulatory & Compliance Strategy](./05_REGULATORY_COMPLIANCE.md)
**Purpose:** Path to regulatory approval

**Key Contents:**
- FDA pathway (Class III PMA)
- Clinical trial strategy (feasibility + pivotal)
- Quality management system (ISO 13485)
- International regulations (CE mark, Health Canada)
- HIPAA and GDPR compliance
- Timeline to approval (36-48 months for FDA)

**Read this if:** You're involved in regulatory affairs, clinical trials, or quality assurance

---

#### 06. [Security & Privacy Plan](./06_SECURITY_PRIVACY.md)
**Purpose:** Comprehensive security strategy

**Key Contents:**
- Threat modeling (STRIDE analysis)
- Security architecture (defense in depth)
- Data protection (encryption, key management)
- Authentication and access control
- Cybersecurity measures (FDA guidance compliance)
- Incident response plan
- HIPAA/GDPR compliance details

**Read this if:** You're responsible for security, privacy, or compliance

---

#### 07. [Development Roadmap: 0 to Launch](./07_DEVELOPMENT_ROADMAP.md)
**Purpose:** Complete timeline and execution plan

**Key Contents:**
- Phase 0: Foundation (Months 1-6)
- Phase 1: MVP Development (Months 7-12)
- Phase 2: Clinical Validation (Months 13-30)
- Phase 3: Regulatory Approval (Months 31-48)
- Phase 4: Launch Preparation (Months 49-52)
- Team scaling plan
- Budget allocation
- Key milestones and decision gates

**Read this if:** You want to understand the overall timeline, phases, and resource needs

---

#### 08. [Risk Assessment & Mitigation Plan](./08_RISK_ASSESSMENT.md)
**Purpose:** Identify and mitigate risks (ISO 14971 compliant)

**Key Contents:**
- Clinical risks (hypoglycemia, DKA, device failure)
- Technical risks (software bugs, ML errors, cybersecurity)
- Regulatory risks (FDA approval delays)
- Business risks (market adoption, competition)
- FMEA (Failure Mode Effects Analysis)
- Risk mitigation strategies

**Read this if:** You're involved in risk management, quality, or safety

---

#### 09. [Testing & Validation Strategy](./09_TESTING_VALIDATION.md)
**Purpose:** Comprehensive testing approach

**Key Contents:**
- Software testing (unit, integration, E2E)
- Algorithm validation (simulation, clinical)
- Device interoperability testing
- Performance and load testing
- Security testing (penetration testing)
- Clinical validation (feasibility + pivotal trials)
- Regression testing strategy

**Read this if:** You're responsible for QA, testing, or validation

---

## Quick Start Guide

### For New Team Members

**Week 1:**
1. Read the [Product Requirements Document](./01_PRODUCT_REQUIREMENTS.md) (2 hours)
2. Skim the [Development Roadmap](./07_DEVELOPMENT_ROADMAP.md) to understand timeline (1 hour)
3. Review the [Risk Assessment](./08_RISK_ASSESSMENT.md) to understand safety considerations (1 hour)

**Week 2:**
4. Deep dive into your domain:
   - Engineers → [System Architecture](./02_SYSTEM_ARCHITECTURE.md) + [Technical Design](./03_TECHNICAL_DESIGN.md)
   - Data Scientists → [ML/AI Strategy](./04_ML_AI_STRATEGY.md)
   - Regulatory → [Regulatory & Compliance](./05_REGULATORY_COMPLIANCE.md)
   - Security → [Security & Privacy Plan](./06_SECURITY_PRIVACY.md)
   - QA → [Testing Strategy](./09_TESTING_VALIDATION.md)

### For Executives

**Priority Reading:**
1. [Product Requirements Document](./01_PRODUCT_REQUIREMENTS.md) - The "what" and "why"
2. [Development Roadmap](./07_DEVELOPMENT_ROADMAP.md) - Timeline and budget
3. [Risk Assessment](./08_RISK_ASSESSMENT.md) - What could go wrong

**Key Metrics to Track:**
- Time to FDA approval (target: 48 months)
- Budget burn rate (target: $30-50M total)
- Clinical trial results (TIR >70%, zero severe hypoglycemia)
- User adoption (target: 5,000 users in Year 1)

### For Investors

**Due Diligence Reading:**
1. [Product Requirements](./01_PRODUCT_REQUIREMENTS.md) - Market opportunity
2. [Regulatory Strategy](./05_REGULATORY_COMPLIANCE.md) - Path to approval
3. [Development Roadmap](./07_DEVELOPMENT_ROADMAP.md) - Timeline and capital needs
4. [Risk Assessment](./08_RISK_ASSESSMENT.md) - Risk factors

**Investment Highlights:**
- **Market Size:** 1.9M Type 1 Diabetes patients in US, growing market
- **Competitive Advantage:** ML-based personalization, superior UX, broader device compatibility
- **Regulatory Path:** Clear FDA pathway (predicate devices exist)
- **Team:** Experienced founders with medical device and AI expertise

---

## Technology Stack Summary

### Backend
- **Language:** Python 3.12+
- **Framework:** FastAPI
- **Database:** PostgreSQL + TimescaleDB
- **Cache:** Redis
- **ML:** PyTorch, ONNX Runtime
- **Cloud:** AWS (EKS, RDS, S3, etc.)

### Mobile
- **iOS:** Swift 5.9+, SwiftUI, CoreML
- **Android:** Kotlin 1.9+, Jetpack Compose, TensorFlow Lite

### Infrastructure
- **Containers:** Docker + Kubernetes
- **CI/CD:** GitHub Actions
- **Monitoring:** Prometheus + Grafana
- **IaC:** Terraform

---

## Key Milestones

| Milestone | Target Month | Status |
|-----------|--------------|--------|
| Company formation | Month 1 | ⏳ Planned |
| FDA Q-Sub meeting | Month 6 | ⏳ Planned |
| MVP complete | Month 12 | ⏳ Planned |
| ISO 13485 certification | Month 15 | ⏳ Planned |
| Feasibility study results | Month 18 | ⏳ Planned |
| Pivotal trial complete | Month 30 | ⏳ Planned |
| PMA submission | Month 36 | ⏳ Planned |
| FDA approval | Month 48 | ⏳ Planned |
| Commercial launch | Month 52 | ⏳ Planned |

---

## Team Structure (Target)

**Month 6 (Foundation):** ~20 people
- Executive: CEO, CTO, COO, CMO
- Engineering: 8-10 engineers
- Regulatory/Quality: 3-4 specialists
- Clinical: 2-3 CRAs
- Data Science: 2-3 ML engineers

**Month 24 (Clinical Trials):** ~40 people

**Month 48 (Pre-Launch):** ~50 people

**Post-Launch (Year 1):** ~90 people

---

## Budget Overview

| Phase | Duration | Estimated Cost |
|-------|----------|----------------|
| Phase 0: Foundation | Months 1-6 | $3-5M |
| Phase 1: MVP Development | Months 7-12 | $5-7M |
| Phase 2: Clinical Validation | Months 13-30 | $10-15M |
| Phase 3: Regulatory Approval | Months 31-48 | $5-8M |
| Phase 4: Launch Preparation | Months 49-52 | $7-10M |
| **Total** | **52 months** | **$30-50M** |

---

## Regulatory Timeline

```
Month 0-6:    Pre-Submission preparation
Month 6:      FDA Q-Sub meeting
Month 12:     IDE submission
Month 13-18:  Feasibility study (50 participants, 3 months)
Month 19-30:  Pivotal trial (240 participants, 6 months follow-up)
Month 31-36:  PMA preparation and submission
Month 37-48:  FDA review (interactive, may include advisory panel)
Month 48:     FDA approval (target)
Month 52:     Commercial launch
```

---

## Success Criteria

### Clinical (Primary)
- ✅ Time in Range >70% (vs ~50% baseline)
- ✅ Zero severe hypoglycemic events in clinical trials
- ✅ HbA1c reduction >0.5%
- ✅ User satisfaction >4.5/5

### Regulatory
- ✅ FDA PMA approval
- ✅ CE mark (EU)
- ✅ ISO 13485 certification

### Business (Year 1 Post-Launch)
- ✅ 5,000+ active users
- ✅ 90% user retention
- ✅ $6M ARR (Annual Recurring Revenue)
- ✅ Positive unit economics

### Technical
- ✅ 99.9% system uptime
- ✅ Glucose prediction RMSE <20 mg/dL (30-min horizon)
- ✅ <0.5% app crash rate

---

## Next Steps

### Immediate Actions (Month 1)
1. **Funding:** Secure seed round ($2-5M)
2. **Team:** Hire CEO, CTO, VP Regulatory, VP Clinical
3. **Legal:** Incorporate, file patents
4. **Partnerships:** Begin discussions with Dexcom, Omnipod

### Month 2-3 Actions
5. **Team Expansion:** Hire engineering team (5-8 engineers)
6. **Regulatory:** Engage FDA consultants, begin Q-Sub preparation
7. **Infrastructure:** Set up development environment, AWS accounts
8. **Clinical:** Form clinical advisory board

### Month 4-6 Actions
9. **Regulatory:** Submit Pre-Submission (Q-Sub) to FDA
10. **Funding:** Close Series A ($10-15M)
11. **Development:** Begin MVP development
12. **Clinical:** Draft clinical trial protocol

---

## Contact & Governance

### Document Ownership
- **Overall Owner:** CEO / CTO
- **Product:** Product Manager
- **Technical:** VP Engineering
- **Regulatory:** VP Regulatory Affairs
- **Clinical:** VP Clinical Affairs
- **Quality:** Quality Manager

### Document Updates
- **Review Frequency:** Quarterly
- **Major Updates:** When strategy changes
- **Version Control:** All documents version-controlled in Git

### Approval Process
All documents require approval from:
- CEO
- CTO
- Relevant department head (VP Engineering, VP Regulatory, etc.)
- Quality Assurance Lead

---

## Disclaimer

This planning documentation represents the initial strategic plan for the closed-loop diabetes management system. All timelines, budgets, and technical specifications are estimates and subject to change based on:
- Regulatory feedback
- Clinical trial results
- Technology developments
- Market conditions
- Funding availability

**This is not a commitment or guarantee of any product, timeline, or outcome.**

---

## References & Resources

### Regulatory Resources
- FDA Guidance: "Artificial Pancreas Device Systems" (2018)
- FDA Pre-Submissions (Q-Subs): https://www.fda.gov/medical-devices/premarket-submissions/pre-submissions
- ISO 13485:2016 - Medical Device Quality Management
- IEC 62304 - Medical Device Software Lifecycle

### Clinical Resources
- American Diabetes Association (ADA) Standards of Care
- JDRF (Juvenile Diabetes Research Foundation)
- UVA/Padova T1D Simulator: https://www.healthsim.org/

### Technical Resources
- OWASP Mobile Security Testing Guide
- NIST Cybersecurity Framework
- HL7 FHIR Standard (healthcare data exchange)

### Competitive Analysis
- Medtronic 780G
- Tandem Control-IQ
- Insulet Omnipod 5
- Beta Bionics iLet
- Diabeloop DBLG1

---

## Version History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | 2025-11-23 | Planning Team | Initial comprehensive planning documents created |

---

**Last Updated:** 2025-11-23
**Status:** Draft - Planning Phase
**Next Review:** TBD (after company formation)
